ALR Technologies Inc.
ALRT
Other OTC0.03
USD
+0.00
- -
CIK
0001087022
ISIN
US0016301022
CUSIP
001630102
Return %
Stock
S&P500
1Y
-35.90
26.53
3Y
-25.00
76.60
5Y
-37.66
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Sidney S. Chan
- Full Time Employees
- 6
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 7400 Beaufont Springs Drive Richmond VA United States of America 23225
- IPO Date
- Mar 14, 2000
- CIK
- 0001087022
- Website
- alrt.com
- Similar Companies
- Business
- ALR Technologies SG Ltd. (OTC: ALRTF) is a medical technology company that develops data-driven solutions for chronic disease management, primarily focused on diabetes care for humans and animals; its core offerings include the ALRT Diabetes Solution, an FDA-cleared, HIPAA-compliant remote monitoring platform that collects data from blood glucose meters and continuous glucose monitors (CGMs), processes it with proprietary algorithms for predictive A1C tracking and insulin dosing adjustments, and facilitates clinician-patient interactions to optimize therapies and adherence; and the GluCurve Pet CGM, the first continuous glucose monitoring system designed specifically for diabetic cats and dogs, paired with a veterinary patient management portal. Founded in 1998 and headquartered in Richmond, Virginia, with key operations in Singapore, the United States, and other regions, the company serves healthcare providers, veterinarians, and patients globally through its software platforms and hardware integrations. Recent developments include a co-branded distribution partnership with Covetrus Inc. announced in December 2022 for exclusive sales of GluCurve Pet CGM to veterinary clinics in the U.S., Brazil, U.K., EU, and select global markets; a definitive manufacturing agreement completed in June 2025 with CGM Medical Technology Shen Zhen Ltd. in China, granting ALRT exclusive global rights to distribute CGM hardware for animal health and anticipating first commercial shipments in Q3 2025; a patent grant in Singapore for its Predictive A1C technology; and plans for a joint venture to establish automated CGM manufacturing in Singapore, alongside ongoing human health commercialization efforts.